CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2021	Nov. 01, 2020
Cash flows from operating activities:
Net earnings	$ 723,396	$ 371,759
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation and amortization	145,897	140,340
Loss on disposal/impairment of assets	887	26,220
Amortization of deferred lease incentives	(3,345)	(4,538)
Non-cash lease expense	159,757	162,767
Deferred income taxes	(11,440)	(6,969)
Tax benefit related to stock-based awards	10,838	13,143
Stock-based compensation expense	70,566	54,671
Other	4	(9)
Changes in:
Accounts receivable	4,941	(18,017)
Merchandise inventories	(264,094)	(22,990)
Prepaid expenses and other assets	(10,078)	(4,807)
Accounts payable	74,181	54,279
Accrued expenses and other liabilities	24,400	58,539
Gift card and other deferred revenue	58,189	59,953
Operating lease liabilities	(164,569)	(171,245)
Income taxes payable	(31,191)	13,532
Net cash provided by operating activities	788,339	726,628
Cash flows from investing activities:
Purchases of property and equipment	(141,010)	(124,885)
Other	97	506
Net cash used in investing activities	(140,913)	(124,379)
Cash flows from financing activities:
Repurchases of common stock	(652,699)	(109,048)
Repayment of long-term debt	(300,000)	0
Payment of dividends	(135,201)	(116,761)
Tax withholdings related to stock-based awards	(102,482)	(30,555)
Debt issuance costs	(777)	(3,645)
Borrowings under revolving line of credit	0	487,823
Repayments under revolving line of credit	0	(487,823)
Net cash used in financing activities	(1,191,159)	(260,009)
Effect of exchange rates on cash and cash equivalents	294	(1,232)
Net (decrease) increase in cash and cash equivalents	(543,439)	341,008
Cash and cash equivalents at beginning of period	1,200,337	432,162
Cash and cash equivalents at end of period	$ 656,898	$ 773,170